Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Cureus ; 14(5), 2022.
Article in English | EuropePMC | ID: covidwho-1877244

ABSTRACT

Mucormycosis is an aggressive opportunistic fungal infection that affects blood supply-rich areas such as the maxilla. Because of the compromised immune system caused by coronavirus disease 2019 (COVID-19) infection and diabetes, this infection has spread at a rapid rate. Early detection and treatment can reduce disease mortality and morbidity. However, the difficulties of prosthetic rehabilitation and the lack of multidisciplinary planning negatively influence the quality of life (QOL). This case report uses the novel concept of magnet-retained immediate prosthetic rehabilitation in such a case.

2.
J Med Virol ; 94(5): 1876-1885, 2022 05.
Article in English | MEDLINE | ID: covidwho-1777591

ABSTRACT

COVID's Omicron variant has sparked a slew of concerns across the globe. This review aims to provide a brief overview of what we know about the Omicron variant right now. The new variant has been discovered in 149 countries across all six World Health Organization (WHO) regions since its discovery in South Africa on November 24, 2021 and became the dominant variant in the country in less than 3 weeks. The WHO has warned that the B.1.1.529 variant is spreading at an unprecedented rate, and has urged countries to prepare for the worst. Over the course of this time, researchers from Africa and around the world have uncovered a wealth of information about the virus's epidemiology and biological properties. Case numbers are increasing exponentially in hard-hit areas such as South Africa, United Kingdom, and USA (overtaking the delta variant), implying that the variant is highly transmissible. Initial research has provided some insights into the efficacy of vaccines against the Omicron variant and whether it produces major illness, however, much remains unknown, and additional work is needed to investigate what the initial reports represent in real-world situations.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/epidemiology , Humans , SARS-CoV-2/genetics , South Africa/epidemiology , World Health Organization
3.
Acta Medica (Hradec Kralove) ; 64(4): 227-231, 2021.
Article in English | MEDLINE | ID: covidwho-1743012

ABSTRACT

Coronavirus infectious disease-19 caused by Severe acute respiratory distress syndrome-coronavirus-2 has emerged to be an emergency global health crisis for more than a year. And, as the disease has spread, a number of new clinical features have been observed in these patients. Immunosuppression caused by this disease results in an exacerbation of pre-existing infections. While corticosteroids are considered a life-saving therapeutic intervention for this pandemic, they have proved to be a double-edged sword and their indiscriminate use has produced some deleterious results. Recently, in the backdrop of this expression, a notable rise in invasive fungal infections has been identified even in the post-remission phase. Mucormycosis, Aspergillosis, and Candidiasis are the three most common opportunistic fungal infections among those observed. COVID-19 patients with diabetes mellitus are already at a higher risk of developing such secondary infections due to impaired immunity. Here we present a rare case report of a 50-year old male diabetic mellitus patient diagnosed with dual fungal infections (Aspergillosis along with Mucormycosis) leading to maxillary sinusitis as a post-COVID manifestation. To our knowledge, this is the first such case reported till date.


Subject(s)
Aspergillosis , COVID-19 , Diabetes Mellitus , Maxillary Sinusitis , Mucormycosis , Mycoses , Aspergillosis/complications , Aspergillosis/diagnosis , Aspergillosis/therapy , COVID-19/complications , Humans , Male , Maxillary Sinusitis/complications , Middle Aged , Mucormycosis/complications , Mucormycosis/diagnosis , Mucormycosis/therapy , Mycoses/complications , SARS-CoV-2
4.
Acta Medica (Hradec Kralove) ; 64(4): 218-223, 2021.
Article in English | MEDLINE | ID: covidwho-1743011

ABSTRACT

BACKGROUND: The second wave of COVID-19 has emerged with the addition of vivid types of oral manifestations. Immunosuppression caused by COVID-19 results in an exacerbation of pre-existing infections. Recently, in the backdrop of COVID-19 expression, a notable rise in the incidence of secondary infections, both fungal and bacterial, have been reported either during the disease or as a post-COVID manifestation. CASE PRESENTATION: A 70-year-old male diabetic COVID-19 patient reported with a chief complaint of pain in the right side maxillary region for 3 months and the passage of content from the oral cavity into the nose. Intraoral examination revealed missing teeth i.r.t. 12 to 17, denuded mucosa with exposed necrotic bone and an oroantral opening. Sequestrectomy was done and the tissue was sent for histopathological examination which revealed necrotic bone interspersed with broad aseptate fungal hyphae branched at right angles along with actinomycotic colonies and Candidal hyphae in few areas. Based on histopathological findings, a final diagnosis of mixed infections leading to Maxillary Osteomyelitis was given. No recurrence was noticed after 3 months of follow up. CONCLUSIONS: The occurrence of oral infections even after the remission period of COVID-19 signifies an alarming sign both for the patient and clinicians monitoring the oral health status during the follow-up period. To our knowledge, this is the first such case (three oral infections as a post covid manifestation in a single diabetic patient) reported in the literature till date.


Subject(s)
Actinomycosis , COVID-19 , Candidiasis , Coinfection , Diabetes Mellitus , Mucormycosis , Osteomyelitis , Aged , COVID-19/complications , Candidiasis/complications , Coinfection/complications , Humans , Male , Mucormycosis/complications , Osteomyelitis/microbiology , SARS-CoV-2
5.
AEM Educ Train ; 4(4): 411-414, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-1293133

ABSTRACT

The COVID-19 pandemic has significantly impacted the well-being of our health care professionals, particularly frontline providers in the emergency department (ED). Our ED, located in New York City, was severely affected, exposing the staff to a combination of unique stressors. Our ED Wellness Committee responded by implementing various initiatives focusing on the physical, mental, and social needs of our providers to support them through this difficult time. The initiatives we describe offer a framework that may help other departments understand the importance of provider well-being during a pandemic.

SELECTION OF CITATIONS
SEARCH DETAIL